AMDA - Acid Maltase Deficiency Association

The Official Website of the Acid Maltase Deficiency Association

It is difficult to say what is impossible for the dreams of yesterday are the hopes of today and the reality of tomorrow. - Robert H. Goddard

Recent | Archives

News

Myozyme Produced at the 2000 L Bioreactor Scale to Receive Accelerated Approval

Posted on: February 04, 2009 - Filed under

Myozyme Produced at the 2000 L Bioreactor Scale to Receive Accelerated Approval

View complete article

Other News

View complete archive

Get Involved

Your generous contribution will go a long way into improving the quality of life of Pompe Disease Patients worldwide.

Recently Added Items

BioMarin Receives Orphan Drug Designation from FDA for Pompe Disease was posted in News, last August 30, 2010
Autophagy and It’s Role In Pompe Disease was posted in Webinar, last August 13, 2010
August 2010 Pompe Program Update from Genzyme was posted in News, last August 10, 2010
Inhibition of glycogen biosynthesis via mTORC1 suppression as an adjunct therapy for Pompe disease was posted in Publications, last August 01, 2010
AMDA 2010 Research Grant Opportunity was posted in News, last July 31, 2010

Home | News | About | Research | Patients | Initiatives | Editorials | Links | Contact

© 2009 Acid Maltase Deficiency Association